We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Monopar Therapeutics
MNPR
$736M
| $271K | ﹤0.01% |
4,946
-44
| -0.9% | -$2.66K |
|
2727
Usana Health Sciences
USNA
$394M
| $271K | ﹤0.01% |
15,494
-273
| -2% | -$5.42K |
|
2728
NACCO Industries
NC
$353M
| $270K | ﹤0.01% |
5,203
-68
| -1% | -$3.51K |
|
|
ONC
2729
BeOne Medicines Ltd
ONC
$33.8B
| $270K | ﹤0.01% |
909
-5
| -0.5% | -$1.62K |
|
2730
8x8 Inc
EGHT
$247M
| $270K | ﹤0.01% |
162,512
-5,001
| -3% | -$10.2K |
|
2731
EVgo
EVGO
$200M
| $270K | ﹤0.01% |
156,752
-3,905
| -2% | -$10.4K |
|
2732
Rezolute
RZLT
$480M
| $270K | ﹤0.01% |
88,380
-7,588
| -8% | -$22.8K |
|
2733
USCB Financial Holdings
USCB
$396M
| $269K | ﹤0.01% |
14,483
-165
| -1% | -$3.14K |
|
|
NXDR
2734
Nextdoor Holdings
NXDR
$835M
| $268K | ﹤0.01% |
191,409
-1,357
| -0.7% | -$2.36K |
|
2735
Tredegar Corp
TG
$268M
| $268K | ﹤0.01% |
33,695
-2,607
| -7% | -$21.8K |
|
|
WBTN
2736
WEBTOON Entertainment Inc
WBTN
$1.22B
| $267K | ﹤0.01% |
29,105
+263
| +0.9% | +$2.95K |
|
|
NAGE
2737
Niagen Bioscience
NAGE
$256M
| $267K | ﹤0.01% |
60,576
-1,987
| -3% | -$10.7K |
|
2738
Pure Cycle
PCYO
$257M
| $267K | ﹤0.01% |
26,522
-729
| -3% | -$7.9K |
|
2739
Reservoir Media
RSVR
$700M
| $266K | ﹤0.01% |
27,141
-191
| -0.7% | -$1.58K |
|
2740
LCNB Corp
LCNB
$285M
| $265K | ﹤0.01% |
17,030
-73
| -0.4% | -$1.22K |
|
2741
Editas Medicine
EDIT
$399M
| $265K | ﹤0.01% |
107,200
-2,105
| -2% | -$4.46K |
|
|
VG
2742
Venture Global Inc
VG
$35.6B
| $264K | ﹤0.01% |
16,778
| – | – |
|
2743
OR Royalties Inc
OR
$5.47B
| $264K | ﹤0.01% |
6,946
-940
| -12% | -$38.6K |
|
2744
Banco de Chile
BCH
$20.6B
| $263K | ﹤0.01% |
7,111
-471
| -6% | -$19.4K |
|
2745
Plumas Bancorp
PLBC
$427M
| $263K | ﹤0.01% |
5,389
+141
| +3% | +$6.96K |
|
2746
First National Corp
FXNC
$269M
| $263K | ﹤0.01% |
9,764
+47
| +0.5% | +$1.25K |
|
|
AXIA
2747
AXIA Energia
AXIA
$22.6B
| $263K | ﹤0.01% |
23,274
+6,111
| +36% | +$66.1K |
|
|
ABX
2748
Abacus Global Management
ABX
$996M
| $262K | ﹤0.01% |
33,291
+1,217
| +4% | +$10.6K |
|
2749
NRC Health Common Stock
NRC
$474M
| $262K | ﹤0.01% |
15,437
-434
| -3% | -$7.38K |
|
|
LTM
2750
LATAM Airlines Group S.A.
LTM
$14.4B
| $262K | ﹤0.01% |
5,299
-800
| -13% | -$45.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.